DE602006010042D1 - Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis - Google Patents

Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis

Info

Publication number
DE602006010042D1
DE602006010042D1 DE200660010042 DE602006010042T DE602006010042D1 DE 602006010042 D1 DE602006010042 D1 DE 602006010042D1 DE 200660010042 DE200660010042 DE 200660010042 DE 602006010042 T DE602006010042 T DE 602006010042T DE 602006010042 D1 DE602006010042 D1 DE 602006010042D1
Authority
DE
Germany
Prior art keywords
teroidal
acute
treatment
chronic bronchitis
inflammatory inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200660010042
Other languages
English (en)
Inventor
Jose Sebastian Franzone
Sebastiano Bianco
Giuseppe Zuccari
Claudio Franco Omini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medestea Research and Production SpA
Original Assignee
Medestea Research and Production SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36353659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006010042(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medestea Research and Production SpA filed Critical Medestea Research and Production SpA
Publication of DE602006010042D1 publication Critical patent/DE602006010042D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE200660010042 2005-03-15 2006-03-10 Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis Active DE602006010042D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20050417 ITMI20050417A1 (it) 2005-03-15 2005-03-15 Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
PCT/EP2006/002226 WO2006097247A1 (en) 2005-03-15 2006-03-10 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis

Publications (1)

Publication Number Publication Date
DE602006010042D1 true DE602006010042D1 (de) 2009-12-10

Family

ID=36353659

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200660010042 Active DE602006010042D1 (de) 2005-03-15 2006-03-10 Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis

Country Status (15)

Country Link
US (1) US9132109B2 (de)
EP (1) EP1865966B1 (de)
JP (1) JP5175710B2 (de)
CN (1) CN101163484B (de)
AR (1) AR053032A1 (de)
AT (1) ATE446760T1 (de)
BR (1) BRPI0609827A2 (de)
CA (1) CA2601137A1 (de)
DE (1) DE602006010042D1 (de)
ES (1) ES2332530T3 (de)
IT (1) ITMI20050417A1 (de)
PL (1) PL1865966T3 (de)
PT (1) PT1865966E (de)
RU (1) RU2408376C2 (de)
WO (1) WO2006097247A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
WO2014178891A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
EP3107548B8 (de) 2014-02-20 2022-07-20 Otitopic Inc. Trockenpulverformulierungen zur inhalation
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
CN111346100A (zh) * 2020-04-16 2020-06-30 四川大学华西医院 阿司匹林或其衍生物在制备治疗气道粘液高分泌的药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179605T1 (de) * 1991-02-09 1999-05-15 B S D Bio Science Dev Snc Di O Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
EP0499143B1 (de) 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation
US5883084A (en) * 1998-06-08 1999-03-16 Clarion Pharmaceuticals Inc. Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
DE19900233A1 (de) * 1999-01-07 2000-07-13 Moeller Plast Gmbh Verfahren zur Herstellung eines hochbelastbaren Bauteils aus Kunststoff und hochbelastbares Bauteil
US20020147216A1 (en) 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
EP1379275A4 (de) * 2001-03-14 2005-12-21 Centocor Inc Mit chronisch-obstruktiver lungenkrankheit im zusammenhang stehende, von immunglobulin abgeleitete proteine, zusammensetzungen, verfahren und verwendungen
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
EP1654312B1 (de) * 2003-08-11 2014-01-15 Glaxo Group Limited Pharmazeutuscher dosierinhalator und zugehörige verfahren
RU2006108864A (ru) * 2003-08-22 2007-09-27 Берингер Ингельхайм Фармасьютиклз, Инк. (Us) Способы лечения хронического обструктивного заболевания легких (хозл) и легочной гипертензии

Also Published As

Publication number Publication date
CA2601137A1 (en) 2006-09-21
RU2007138033A (ru) 2009-04-20
ITMI20050417A1 (it) 2006-09-16
WO2006097247A1 (en) 2006-09-21
ATE446760T1 (de) 2009-11-15
US20080306033A1 (en) 2008-12-11
PL1865966T3 (pl) 2010-03-31
JP2008533071A (ja) 2008-08-21
EP1865966B1 (de) 2009-10-28
JP5175710B2 (ja) 2013-04-03
CN101163484A (zh) 2008-04-16
US9132109B2 (en) 2015-09-15
AR053032A1 (es) 2007-04-18
BRPI0609827A2 (pt) 2010-04-27
ES2332530T3 (es) 2010-02-08
RU2408376C2 (ru) 2011-01-10
PT1865966E (pt) 2009-11-26
EP1865966A1 (de) 2007-12-19
CN101163484B (zh) 2010-09-29

Similar Documents

Publication Publication Date Title
ATE539064T1 (de) Heterozyklische inhibitoren von mek und verwendungsverfahren damit
DE602006021323D1 (de) Pyridinderivate und ihre verwendung bei der behandlung psychotischer erkrankungen
ATE474578T1 (de) Verwendung von flibanserin bei der behandlung von prämenstruellen störungen
ATE472546T1 (de) 5-heteroarylthiazole und deren verwendung als pi3k-inhibitoren
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
DOP2006000066A (es) Nueva sal y polimorfos del inhibidor de la dpp-iv
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005012825D1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DE502005008522D1 (de) Verwendung von Polyolefinwachsen in Heissschmelzmassen
ATE435859T1 (de) Gyraseinhibitoren und deren verwendungen
ATE477249T1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
ATE543795T1 (de) Kondensierte bicyclische carbonsäureamidderivate zur verwendung als cxcr2-inhibitoren bei der behandlung von entzündungen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
DK1765376T3 (da) Topiske sammensætninger og anvendelse deraf til behandling af epitel-relaterede tilstande
DE502006001336D1 (de) Verwendung von acetalen in wasch- und reinigungsmitteln
DE602006010042D1 (de) Verwendung von nichtsteroidalen entzündungshemmern bei der behandlung von akuter und chronischer bronchitis
ATE524183T1 (de) Verwendung von sanglifehrin bei der hcv-therapie
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
ZA200805296B (en) Allergy inhibitor compositions and kits and methods of using the same
ATE489091T1 (de) Dha-ester und ihre verwendung bei der behandlung und der prävention von kardiovaskulären erkrankungen
DK2124997T3 (da) Anvendelse af IL-1-antagonister til behandling af gigt og pseudogigt
ATE468338T1 (de) Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer
DK1831227T3 (da) Hidtil ukendte, heterocykliske forbindelser, der er anvendelige til behandling af inflammatoriske og allergiske forstyrrelser
EP1883404A4 (de) P38-hemmer und anwendungsverfahren dafür
ATE479716T1 (de) Copolymerisate und ihre verwendung zur behandlung von flexiblen substraten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition